Changes of liver enzymes and triglyceride during the menopausal transition in Japanese women

References

• Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. 2005. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44–52.
   PubMed Web of Science ®Google Scholar
• Carr MC. 2003. The emergence of the metabolic syndrome with menopause. Journal of Clinical Endocrinology Metabolism 88:2404–2411.
   PubMed Web of Science ®Google Scholar
• Chang Y, Ryu S, Sung E, Jang Y. 2007. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clinical Chemistry 53:686–692.
   PubMed Web of Science ®Google Scholar
• Chen Z, Han CK, Pan LL, Zhang HJ, Ma ZM, Huang ZF, et al. 2014. Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects. Digestive Diseases and Sciences 59:2470–2476.
   PubMed Web of Science ®Google Scholar
• Cheung E, Tsang S, Bow C, Soong C, Yeung S, Loong C, et al. 2011. Bone loss during menopausal transition among southern Chinese women. Maturitas 69:50–56.
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. 2007. Asia-Pacific working party on NAFLD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. Journal of Gastroenterology Hepatology 22:778–787.
   PubMed Web of Science ®Google Scholar
• Clark JM, Brancati FL, Diehl AM. 2003. The prevalence and etiology of elevated aminotransferase levels in the United States. American Journal of Gastroenterology 98:960–967.
   PubMed Web of Science ®Google Scholar
• Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. 2009. Lipid changes during the menopause transition in relation to age and weight: the study of women's health across the nation. American Journal of Epidemiology 169:1352–1361.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M, Méndez-Sánchez N. 2010. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Annals of Hepatology 9:402–409.
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. 2005. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Annals of Internal Medicine 143:722–728.
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. 2005. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54:3140–3147.
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB Jr, Haffner SM. 2007. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the insulin resistance atherosclerosis study. Diabetes Care 30:1819–1827.
   PubMed Web of Science ®Google Scholar
• Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. 2005. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetic Medicine 22:1141–1145.
   PubMed Web of Science ®Google Scholar
• Kuller LH, Gutai JP, Meilahn E, Matthews KA, Plantinga P. 1990. Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women. Arteriosclerosis 10:1058–1066.
   PubMedGoogle Scholar
• Liangpunsakul S, Chalasani N. 2005. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third national health and nutrition survey (NHANES III). American Journal of Medical Science 329:111–116.
   PubMed Web of Science ®Google Scholar
• Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. 2009. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of American College of Cardiology 54:2366–2373.
   PubMed Web of Science ®Google Scholar
• Matsui S, Yasui T, Tani A, Kato T, Kunimi K, Uemura H, et al. 2012. Association of circulating adiponectin with testosterone in women during the menopausal transition. Maturitas 73:255–260.
   PubMed Web of Science ®Google Scholar
• Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH. 2005. Atherosclerosis risk in communities study. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. Journal of Clinical Endocrinology and Metabolism 90:1202–1209.
   PubMed Web of Science ®Google Scholar
• Ossewaarde ME, Bots ML, van der Schouw YT, Thijssen JH, Westerveld HT, de Jong FH, et al. 2003. Plasma and urinary sex hormones are differently related to lipids in healthy postmenopausal women. Maturitas 44:181–187.
   PubMed Web of Science ®Google Scholar
• Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. 2006. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metabolism Research and Reviews 22:437–443.
   PubMed Web of Science ®Google Scholar
• Shelley JM, Green A, Smith AM, Dudley E, Dennerstein L, Hopper J, et al. 1998. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Annals of Epidemiology 8:39–45.
   PubMed Web of Science ®Google Scholar
• Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. 2001. Stages of reproductive aging workshop (STRAW). Journal of Women's Health Gender Based Medicine 10:843–848.
   PubMedGoogle Scholar
• Tzima N, Pitsavos C, Panagiotakos DB, Chrysohoou C, Polychronopoulos E, Skoumas J, et al. 2009. Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study. Nutrition and Metabolism (Lond) 6:30.
   PubMed Web of Science ®Google Scholar
• Uemura H, Katsuura-Kamano S, Yamaguchi M, Sawachika F, Arisawa K. 2014. Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population. PLoS One 9:e95981
   PubMed Web of Science ®Google Scholar
• Vernon G, Baranova A, Younossi ZM. 2011. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology and Therapeutics 34:274–285.
   PubMed Web of Science ®Google Scholar
• Westerbacka J, Cornér A, Tiikkainen M, Tamminen M, Vehkavaara S, Häkkinen AM, et al. 2004. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47:1360–1369.
   PubMed Web of Science ®Google Scholar
• Woodard GA, Brooks MM, Barinas-Mitchell E, Mackey RH, Matthews KA, Sutton-Tyrrell K. 2011. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 18:376–384.
   PubMed Web of Science ®Google Scholar
• Xu Y, Bi YF, Xu M, Huang Y, Lu WY, Gu YF, et al. 2011. Cross-sectional and longitudinal association of serum alanine aminotransaminase and γ-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people. Journal of Diabetes 3:38–47.
   PubMed Web of Science ®Google Scholar
• Zhou JL, Lin SQ, Shen Y, Chen Y, Zhang Y, Chen FL. 2010. Serum lipid profile changes during the menopausal transition in Chinese women: a community-based cohort study. Menopause 17:997–1003.
   PubMed Web of Science ®Google Scholar